ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
144.56
-2.19 (-1.49%)
Jun 27, 2025, 4:00 PM - Market closed
ICLR Revenue
ICON Public Limited Company had revenue of $2.00B in the quarter ending March 31, 2025, a decrease of -4.26%. This brings the company's revenue in the last twelve months to $8.19B, down -0.48% year-over-year. In the year 2024, ICON Public Limited Company had annual revenue of $8.28B with 1.99% growth.
Revenue (ttm)
$8.19B
Revenue Growth
-0.48%
P/S Ratio
1.44
Revenue / Employee
$195,528
Employees
41,900
Market Cap
11.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.28B | 161.50M | 1.99% |
| Dec 31, 2023 | 8.12B | 378.79M | 4.89% |
| Dec 31, 2022 | 7.74B | 2.26B | 41.24% |
| Dec 31, 2021 | 5.48B | 2.68B | 95.93% |
| Dec 31, 2020 | 2.80B | -8.55M | -0.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ICLR News
- 3 days ago - ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued? - Seeking Alpha
- 5 days ago - ICON plc Schedules Second Quarter 2025 Earnings Conference Call - Business Wire
- 26 days ago - ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR - PRNewsWire
- 4 weeks ago - ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - Business Wire
- 5 weeks ago - ICON releases its ICON Cares 2024 Report - Business Wire
- 7 weeks ago - Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies - Business Wire
- 2 months ago - ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ICON Reports First Quarter 2025 Results - Business Wire